Su et al. [37] reported that MARCH1 suppressed bladder cancer growth, while Xu et al. [38] demonstrated that MARCH1 expression was decreased significantly in colon adenocarcinoma (COAD), lung adenocarcinoma, lung squamous cell carcinoma (LUSC), prostate adenocarcinoma (PAAD), and rectum adenocarcinoma (READ). The gene discussed is MARCHF1; the disease is prostate adenocarcinoma.